Publications by authors named "Michelle Kenyon"

Claim this Profile
A
Advancing the Integration of 'Basic/Fundamental' and Translational Cellular and Gene Therapy Science within the EBMT: Accelerating the Pathway to Progress.
Donal P McLornan, Mette D Hazenberg, Fabio Ciceri, Tobias Alexander, Emanuele Angelucci, Michelle Kenyon

Bone Marrow Transplant· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of liver sinusoidal obstruction syndrome/veno-occlusive disease in adults: a 2025 perspective from an international expert group.
Marion Larue, Florent Malard, Ahmed S Alaskar, Mahmoud Aljurf, Mutlu Arat, Michelle Kenyon

Bone Marrow Transplant· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of allo-HCT in "nonclassical" MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMT.
Nicola Polverelli, Juan Carlos Hernández-Boluda, Francesco Onida, Carmelo Gurnari, Kavita Raj, Michelle Kenyon

Blood· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An international survey to better understand the current incidence, severity, and management of VOD/SOS.
Marion Larue, Myriam Labopin, Eolia Brissot, Ahmed S Alaskar, Mahmoud Aljurf, Michelle Kenyon

Bone Marrow Transplant· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-Nitrosamine drug substance related impurities (NDSRIs) - A proposal for the addition of subcategories to carcinogenic potency categorization approach categories 1 and 2 for NDSRIs with a molecular weight > 200 Da.
Joel Bercu, Olivier Dirat, Krista Dobo, Robert Jolly, Michelle Kenyon

Regul Toxicol Pharmacol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nurses' reported training needs for advanced cell therapies: a survey on behalf of the Nurses Group of the EBMT.
Michelle Kenyon, Sarah Jayne Liptrott, Annika Kisch, Jarl Mooyaart, Brian Piepenbroek

Clin Hematol Int· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient engagement in hematopoietic stem cell transplantation and cell therapy: a survey by the EBMT patient engagement task force & transplantation complications working party.
Hélène Schoemans, Linda J Burns, Sarah J Liptrott, John Murray, Michelle Kenyon

Bone Marrow Transplant· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes in HSCT for autoimmune diseases: Considerations on behalf of the EBMT ADWP, PAC, and Nurses Group.
Tobias Alexander, Noëlle Tassy, Ariadna Domenech, Ellen Kramer, Helen Jessop, Michelle Kenyon

J Allergy Clin Immunol Glob· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Kinetic Model for Assessing Potential Nitrosamine Carcinogenicity.
Shu Yu, J Christopher McWilliams, Olivier Dirat, Krista L Dobo, Amit S Kalgutkar, Michelle O Kenyon

Chem Res Toxicol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of non-mutagenic substances in the context of drug impurity assessment - Few are potent toxicants.
Catrin Hasselgren, Michelle Kenyon, Lennart T Anger, Paul Cornwell, Eric Watt

Regul Toxicol Pharmacol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deriving acceptable limits for non-mutagenic impurities in medicinal products - Durational adjustments.
Michelle O Kenyon, Matthew Martin, Elizabeth A Martin, Susanne Brandstetter, Teresa Wegesser

Regul Toxicol Pharmacol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing (IWGT).
Barbara L Parsons, Marc A Beal, Kerry L Dearfield, George R Douglas, Min Gi, Michelle Kenyon

Environ Mol Mutagen· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nutritional aspects in autoimmune diseases undergoing hematopoietic stem cell transplantation: overview and recommendations on behalf of the EBMT ADWP and Nurses Group.
Chiara Gandossi, Helen Jessop, Anne Hahn, Lisa Heininger, Jörg Henes, Michelle Kenyon

Front Nutr· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haploidentical Transplant with Post-Transplant Cyclophosphamide for Acute Myeloid Leukaemia and Myelodysplastic Syndromes Patients: The Role of Previous Lines of Therapy.
Daniele Avenoso, Fabio Serpenti, Liron Barnea Slonim, Styliani Bouziana, Francesco Dazzi, Michelle Kenyon

Mediterr J Hematol Infect Dis· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT.
Carmelo Gurnari, Marie Robin, Lucy A Godley, Joanna Drozd-Sokołowska, Marcin W Włodarski, Michelle Kenyon

Lancet Haematol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloablative Dose of Busulfan and Fludarabine Combined with In Vivo T Cell Depletion Is Safe and Effective Conditioning for Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients.
Daniele Avenoso, Varun Mehra, Liron Barnea Slonim, Madson de Farias, Hassan Alshehri, Michelle Kenyon

Transplant Cell Ther· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the utility of common arguments used in expert review of in silico predictions as part of ICH M7 assessments.
Alex N Cayley, Robert S Foster, Alessandro Brigo, Wolfgang Muster, Alyssa Musso, Michelle O Kenyon

Regul Toxicol Pharmacol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The European Society for Blood and Marrow Transplantation (EBMT) roadmap and perspectives to improve nutritional care in patients undergoing hematopoietic stem cell transplantation on behalf of the Cellular Therapy and Immunobiology Working Party (CTIWP) and the Nurses Group (NG) of the EBMT.
Amanda Casirati, Isabel Salcedo, Emanuele Cereda, Christian Chabannon, Annalisa Ruggeri, Michelle Kenyon

Bone Marrow Transplant· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acceptable intakes (AIs) for 11 small molecule N-nitrosamines (NAs).
Joel P Bercu, Melisa Masuda-Herrera, Alejandra Trejo-Martin, Priyanka Sura, Robert Jolly, Michelle Kenyon

Regul Toxicol Pharmacol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT).
Mohamad Mohty, Florent Malard, Ahmed S Alaskar, Mahmoud Aljurf, Mutlu Arat, Michelle Kenyon

Bone Marrow Transplant· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fludarabine-Melphalan-Campath, Followed by Unmanipulated Peripheral-Blood Haematopoietic Stem Cells, Can Still Cure Lymphoma.
Daniele Avenoso, Amal Alabdulwahab, Michelle Kenyon, Varun Mehra, Pramila Krishnamurthy

Mediterr J Hematol Infect Dis· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE).
Riccardo Saccardi, Hein Putter, Dirk-Jan Eikema, María Paula Busto, Eoin McGrath, Michelle Kenyon

Bone Marrow Transplant· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practice harmonization workshops of EBMT: an expert-based approach to generate practical and contemporary guidelines within the arena of hematopoietic cell transplantation and cellular therapy.
Ibrahim Yakoub-Agha, Raffaella Greco, Francesco Onida, Rafael de la Cámara, Fabio Ciceri, Michelle Kenyon

Bone Marrow Transplant· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies for Assessing Acceptable Intakes for Novel -Nitrosamines Derived from Active Pharmaceutical Ingredients.
David J Ponting, Krista L Dobo, Michelle O Kenyon, Amit S Kalgutkar

J Med Chem· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis